Abstract
Human umbilical cord blood (hUCB) is a primitive source of stem cells and is being banked worldwide for the purpose of future clinical use. Lineage negative (Lin-ve) stem cells are one of the primitive populations in hUCB which are capable of self-renewal and differentiation into multiple lineages. These cells have not been adequately investigated for their stem cell characteristics. We have analyzed the immunophenotypic expression of CD45, CD34 and CD117 markers on three different cell populations in hUCB viz., mononucleated cells (MNCs), Lineage positive (Lin+ve) and Lin-ve cells. The CD34 and CD117 expression was found to be 60 fold more in the Lin-ve population as compared to MNCs and Lin+ve cells. This expression was further enhanced in CD45+Lin-ve fraction. The CD34+ and CD117+ Lin-ve cells showed 99% positivity for CD45. Our data suggest that CD34+ CD117+ Lin-ve cells are reasonably enriched stem cell population in hUCB which can be clinically used for transplantation and other therapeutic purposes.
Keywords: CD117, CD34, haematopoietic, lineage, stem cell, umbilical cord blood.
Current Neurovascular Research
Title:An Enriched Population of CD45, CD34 and CD117 Stem Cells in Human Umbilical Cord Blood for Potential Therapeutic Regenerative Strategies
Volume: 11 Issue: 4
Author(s): Avijit Banik, Sudesh Prabhakar, Jasvinder Kalra and Akshay Anand
Affiliation:
Keywords: CD117, CD34, haematopoietic, lineage, stem cell, umbilical cord blood.
Abstract: Human umbilical cord blood (hUCB) is a primitive source of stem cells and is being banked worldwide for the purpose of future clinical use. Lineage negative (Lin-ve) stem cells are one of the primitive populations in hUCB which are capable of self-renewal and differentiation into multiple lineages. These cells have not been adequately investigated for their stem cell characteristics. We have analyzed the immunophenotypic expression of CD45, CD34 and CD117 markers on three different cell populations in hUCB viz., mononucleated cells (MNCs), Lineage positive (Lin+ve) and Lin-ve cells. The CD34 and CD117 expression was found to be 60 fold more in the Lin-ve population as compared to MNCs and Lin+ve cells. This expression was further enhanced in CD45+Lin-ve fraction. The CD34+ and CD117+ Lin-ve cells showed 99% positivity for CD45. Our data suggest that CD34+ CD117+ Lin-ve cells are reasonably enriched stem cell population in hUCB which can be clinically used for transplantation and other therapeutic purposes.
Export Options
About this article
Cite this article as:
Banik Avijit, Prabhakar Sudesh, Kalra Jasvinder and Anand Akshay, An Enriched Population of CD45, CD34 and CD117 Stem Cells in Human Umbilical Cord Blood for Potential Therapeutic Regenerative Strategies, Current Neurovascular Research 2014; 11 (4) . https://dx.doi.org/10.2174/1567202611666140902144836
DOI https://dx.doi.org/10.2174/1567202611666140902144836 |
Print ISSN 1567-2026 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5739 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Small Molecules and Future Regenerative Medicine
Current Topics in Medicinal Chemistry Morphofunctional Aspects of the Blood-Brain Barrier
Current Drug Metabolism Analgesic Considerations for Liver Transplantation Patients
Current Clinical Pharmacology Osteogenic Differentiation Factors of Multipotent Mesenchymal Stromal Cells in the Current Understanding
Current Pharmaceutical Design Pathophysiological Role of Mitochondrial Potassium Channels and their Modulation by Drugs
Current Medicinal Chemistry Polyphenols as Potential Therapeutics for Pain and Inflammation in Spinal Cord Injury
Current Molecular Pharmacology Reorganizing Metals: the Use of Chelating Compounds as Potential Therapies for Metal-Related Neurodegenerative Disease
Current Topics in Medicinal Chemistry NMDA Receptors are not Alone: Dynamic Regulation of NMDA Receptor Structure and Function by Neuregulins and Transient Cholesterol-Rich Membrane Domains Leads to Disease-Specific Nuances of Glutamate- Signalling
Current Topics in Medicinal Chemistry TRP Channels and Pain
Current Pharmaceutical Design Remediation of Cellular Hypoxic Damage by Pharmacological Agents
Current Pharmaceutical Design Intrathecal Administration of Melatonin Ameliorates the Neuroinflammation- Mediated Sensory and Motor Dysfunction in A Rat Model of Compression Spinal Cord Injury
Current Molecular Pharmacology Self-Assembling Peptide Nanofibrous Scaffolds for Tissue Engineering: Novel Approaches and Strategies for Effective Functional Regeneration
Current Protein & Peptide Science Objective Biomarkers or Symptom Scores for the Classification of Fibromyalgia Syndrome?
Current Rheumatology Reviews Propofol Promotes Blood-Brain Barrier Breakdown and Heat Shock Protein (HSP 72 kd) Activation in the Developing Mouse Brain
CNS & Neurological Disorders - Drug Targets Targeting Microglial Activation in Stroke Therapy: Pharmacological Tools and Gender Effects
Current Medicinal Chemistry Purinergic (P2) Receptor Control of Lower Genitourinary Tract Function and New Avenues for Drug Action: An Overview
Current Pharmaceutical Design Modelling and Treating Amyotrophic Lateral Sclerosis through Induced- Pluripotent Stem Cells Technology
Current Stem Cell Research & Therapy Meet Our Editorial Board Member
Current Neuropharmacology Clinical Potential of Minocycline for Schizophrenia
CNS & Neurological Disorders - Drug Targets Proteomic Comparison of Damaged Sciatic Nerves of a Newt, Triturus <i>karelinii</i> (Amphibia: Urodela) During the First 24<sup>th</sup> Hour of Regeneration Period
Current Proteomics